US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 39.840
  • +1.490+3.89%
Close Dec 20 16:00 ET
  • 40.339
  • +0.499+1.25%
Post 20:01 ET
142.94MMarket Cap-5.50P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.16%-20.1M
-43.16%-19.49M
-1.60%-22.75M
0.49%-79M
-35.01%-22.66M
-18.67%-20.34M
45.61%-13.62M
-9.56%-22.39M
31.36%-79.39M
55.22%-16.78M
Net income from continuing operations
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
Operating gains losses
--105K
---30.48M
--14.37M
--2.19M
--2.17M
----
----
----
----
----
Depreciation and amortization
-2.06%667K
-20.68%610K
-20.14%674K
-16.49%3.07M
-13.60%775K
-24.83%681K
-13.50%769K
-14.14%844K
-2.73%3.68M
-11.45%897K
Change In working capital
48.69%-3.18M
539.35%4.11M
-49.58%-5.49M
-513.72%-9.53M
-133.87%-293K
-118.07%-6.2M
106.45%643K
-135.31%-3.67M
66.63%-1.55M
119.43%865K
-Change in payables and accrued expense
-12.93%-1.98M
572.70%4M
-56.91%-4.48M
82.46%-1.3M
-1.00%4.15M
-264.63%-1.76M
88.49%-846K
46.50%-2.85M
-178.67%-7.42M
-2.01%4.19M
-Change in other current assets
121.82%170K
-93.63%138K
-90.22%204K
-56.79%2.3M
-105.06%-1.18M
-236.19%-779K
9.62%2.17M
-37.58%2.09M
165.86%5.32M
92.67%-573K
-Change in other current liabilities
-21.57%-699K
-5.17%-631K
-8.90%-636K
-22.23%-2.39M
-1.46%-627K
-52.52%-575K
34.14%-600K
-1,169.57%-584K
-18.37%-1.95M
-11.75%-618K
-Change in other working capital
78.31%-671K
896.05%605K
74.73%-587K
-425.14%-8.14M
-23.62%-2.64M
24.65%-3.09M
97.94%-76K
-118.68%-2.32M
157.40%2.5M
-482.56%-2.14M
Cash from discontinued investing activities
Operating cash flow
1.16%-20.1M
-43.16%-19.49M
-1.60%-22.75M
0.49%-79M
-35.01%-22.66M
-18.67%-20.34M
45.61%-13.62M
-9.56%-22.39M
31.36%-79.39M
55.22%-16.78M
Investing cash flow
Cash flow from continuing investing activities
115,633.33%10.4M
59.95%39.99M
-543.37%-88.64M
271.08%44.98M
-100.06%-7K
-100.03%-9K
350.64%25M
133.10%19.99M
-970.05%-26.29M
170.42%11.6M
Net PPE purchase and sale
-36.84%-26K
-150.00%-7K
-885.71%-69K
97.99%-19K
92.31%-7K
-533.33%-19K
104.19%14K
98.64%-7K
-5.72%-943K
72.92%-91K
Net investment purchase and sale
104,140.00%10.42M
60.06%40M
-542.87%-88.57M
277.51%45M
--0
-99.97%10K
359.18%24.99M
133.40%20M
-747.68%-25.35M
172.45%11.7M
Cash from discontinued investing activities
Investing cash flow
115,633.33%10.4M
59.95%39.99M
-543.37%-88.64M
271.08%44.98M
-100.06%-7K
-100.03%-9K
350.64%25M
133.10%19.99M
-970.05%-26.29M
170.42%11.6M
Financing cash flow
Cash flow from continuing financing activities
80.95%-4K
-32.13%281K
-1,800.00%-19K
53,758.54%88.33M
72,574.38%87.94M
-10.53%-21K
398.80%414K
95.24%-1K
-99.79%164K
-78.08%121K
Net issuance payments of debt
76.19%-5K
65.96%-16K
20.83%-19K
-57.38%-96K
-114.81%-4K
25.00%-21K
-62.07%-47K
22.58%-24K
22.78%-61K
235.00%27K
Net common stock issuance
----
----
----
--17.44M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--1K
-35.57%297K
--0
31,447.11%70.98M
74,896.81%70.5M
--0
311.61%461K
130.00%23K
-78.51%225K
-86.94%94K
Cash from discontinued financing activities
Financing cash flow
80.95%-4K
-32.13%281K
-1,800.00%-19K
53,758.54%88.33M
72,574.38%87.94M
-10.53%-21K
398.80%414K
95.24%-1K
-99.79%164K
-78.08%121K
Net cash flow
Beginning cash position
-50.32%45.15M
-69.18%24.37M
66.67%135.77M
-56.43%81.46M
-18.51%70.5M
27.64%90.87M
-25.49%79.07M
-56.43%81.46M
-15.37%186.98M
-64.01%86.52M
Current changes in cash
52.34%-9.71M
76.08%20.78M
-4,551.65%-111.41M
151.47%54.31M
1,390.45%65.27M
-232.88%-20.37M
133.79%11.8M
97.04%-2.4M
-210.69%-105.52M
90.53%-5.06M
End cash Position
-49.73%35.44M
-50.32%45.15M
-69.18%24.37M
66.67%135.77M
66.67%135.77M
-18.51%70.5M
27.64%90.87M
-25.49%79.07M
-56.43%81.46M
-56.43%81.46M
Free cash flow
1.09%-20.13M
-43.29%-19.5M
-1.88%-22.82M
1.64%-79.02M
-34.32%-22.67M
-18.72%-20.35M
46.36%-13.61M
-6.90%-22.39M
31.08%-80.33M
55.38%-16.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.16%-20.1M-43.16%-19.49M-1.60%-22.75M0.49%-79M-35.01%-22.66M-18.67%-20.34M45.61%-13.62M-9.56%-22.39M31.36%-79.39M55.22%-16.78M
Net income from continuing operations -6.75%-19.26M126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M
Operating gains losses --105K---30.48M--14.37M--2.19M--2.17M--------------------
Depreciation and amortization -2.06%667K-20.68%610K-20.14%674K-16.49%3.07M-13.60%775K-24.83%681K-13.50%769K-14.14%844K-2.73%3.68M-11.45%897K
Change In working capital 48.69%-3.18M539.35%4.11M-49.58%-5.49M-513.72%-9.53M-133.87%-293K-118.07%-6.2M106.45%643K-135.31%-3.67M66.63%-1.55M119.43%865K
-Change in payables and accrued expense -12.93%-1.98M572.70%4M-56.91%-4.48M82.46%-1.3M-1.00%4.15M-264.63%-1.76M88.49%-846K46.50%-2.85M-178.67%-7.42M-2.01%4.19M
-Change in other current assets 121.82%170K-93.63%138K-90.22%204K-56.79%2.3M-105.06%-1.18M-236.19%-779K9.62%2.17M-37.58%2.09M165.86%5.32M92.67%-573K
-Change in other current liabilities -21.57%-699K-5.17%-631K-8.90%-636K-22.23%-2.39M-1.46%-627K-52.52%-575K34.14%-600K-1,169.57%-584K-18.37%-1.95M-11.75%-618K
-Change in other working capital 78.31%-671K896.05%605K74.73%-587K-425.14%-8.14M-23.62%-2.64M24.65%-3.09M97.94%-76K-118.68%-2.32M157.40%2.5M-482.56%-2.14M
Cash from discontinued investing activities
Operating cash flow 1.16%-20.1M-43.16%-19.49M-1.60%-22.75M0.49%-79M-35.01%-22.66M-18.67%-20.34M45.61%-13.62M-9.56%-22.39M31.36%-79.39M55.22%-16.78M
Investing cash flow
Cash flow from continuing investing activities 115,633.33%10.4M59.95%39.99M-543.37%-88.64M271.08%44.98M-100.06%-7K-100.03%-9K350.64%25M133.10%19.99M-970.05%-26.29M170.42%11.6M
Net PPE purchase and sale -36.84%-26K-150.00%-7K-885.71%-69K97.99%-19K92.31%-7K-533.33%-19K104.19%14K98.64%-7K-5.72%-943K72.92%-91K
Net investment purchase and sale 104,140.00%10.42M60.06%40M-542.87%-88.57M277.51%45M--0-99.97%10K359.18%24.99M133.40%20M-747.68%-25.35M172.45%11.7M
Cash from discontinued investing activities
Investing cash flow 115,633.33%10.4M59.95%39.99M-543.37%-88.64M271.08%44.98M-100.06%-7K-100.03%-9K350.64%25M133.10%19.99M-970.05%-26.29M170.42%11.6M
Financing cash flow
Cash flow from continuing financing activities 80.95%-4K-32.13%281K-1,800.00%-19K53,758.54%88.33M72,574.38%87.94M-10.53%-21K398.80%414K95.24%-1K-99.79%164K-78.08%121K
Net issuance payments of debt 76.19%-5K65.96%-16K20.83%-19K-57.38%-96K-114.81%-4K25.00%-21K-62.07%-47K22.58%-24K22.78%-61K235.00%27K
Net common stock issuance --------------17.44M------------------0----
Proceeds from stock option exercised by employees --1K-35.57%297K--031,447.11%70.98M74,896.81%70.5M--0311.61%461K130.00%23K-78.51%225K-86.94%94K
Cash from discontinued financing activities
Financing cash flow 80.95%-4K-32.13%281K-1,800.00%-19K53,758.54%88.33M72,574.38%87.94M-10.53%-21K398.80%414K95.24%-1K-99.79%164K-78.08%121K
Net cash flow
Beginning cash position -50.32%45.15M-69.18%24.37M66.67%135.77M-56.43%81.46M-18.51%70.5M27.64%90.87M-25.49%79.07M-56.43%81.46M-15.37%186.98M-64.01%86.52M
Current changes in cash 52.34%-9.71M76.08%20.78M-4,551.65%-111.41M151.47%54.31M1,390.45%65.27M-232.88%-20.37M133.79%11.8M97.04%-2.4M-210.69%-105.52M90.53%-5.06M
End cash Position -49.73%35.44M-50.32%45.15M-69.18%24.37M66.67%135.77M66.67%135.77M-18.51%70.5M27.64%90.87M-25.49%79.07M-56.43%81.46M-56.43%81.46M
Free cash flow 1.09%-20.13M-43.29%-19.5M-1.88%-22.82M1.64%-79.02M-34.32%-22.67M-18.72%-20.35M46.36%-13.61M-6.90%-22.39M31.08%-80.33M55.38%-16.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Intchains Group
ICG
+88.60%
BIGG DIGITAL ASSETS INC
BBKCF
+16.25%
NEPTUNE DIGITAL ASSETS CORP
NPPTF
+13.51%
Bitdeer Technologies
BTDR
+12.95%
FRMO CORP
FRMO
+8.72%

Unlock the Full List